PTPRH
protein-codingprotein tyrosine phosphatase receptor type H, the group of Fibronectin type III domain containing|Protein tyrosine phosphatases receptor type
Gene summary
The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and a single intracytoplasmic catalytic domain, and thus represents a receptor-type PTP. The extracellular region contains eight fibronectin type III-like repeats and multiple N-glycosylation sites. The gene was shown to be expressed primarily in brain and liver, and at a lower level in heart and stomach. It was also found to be expressed in several cancer cell lines, but not in the corresponding normal tissues. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~28.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PTPRH variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002842.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | 4 | |||
| missense | 211 | 27 | 238 | |||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 0 | 0 | 216 | 29 | 0 | 245 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002833.4 | 20 | MANE Select | |
| Ensembl | ENSP00000365528.2 | 20 | MANE Select | |
| RefSeq | NP_001154912.2 | 18 | Standard | |
| Ensembl | ENSP00000263434.4 | 18 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- TCR
Biological Process
- protein dephosphorylation
- apoptotic process
- peptidyl-tyrosine dephosphorylation
Molecular Function
- transmembrane receptor protein tyrosine phosphatase activity
- protein binding
Cellular Component
- cytoplasm
- integral component of plasma membrane
- apical plasma membrane
- microvillus membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000376350
- Coding exons
- 20
- Length
- 28259
- Individuals with no LoFs
- 124373
- Homozygous LoFs
- 9
- Heterozygous LoFs
- 1366
- Defined
- 125748
- p
- 0.00548
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.793 | 711 | 654 | 1.09 | 0.0000378 | 7192 |
| Missense (PolyPhen) | 198 | 203.36 | 0.97365 | 2328 | ||
| Synonymous | -0.502 | 294 | 283 | 1.04 | 0.0000192 | 2279 |
| Loss of Function | 0.375 | 57 | 60.1 | 0.948 | 0.00000319 | 594 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0013 | 0.0013 | notable |
| Latino/Admixed American | 0.0059 | 0.0058 | notable |
| Ashkenazi Jewish | 0.025 | 0.024 | notable |
| East Asian | 0.0013 | 0.0013 | notable |
| Finnish | 0.00097 | 0.00097 | rare |
| European (Non-Finnish) | 0.0061 | 0.0060 | notable |
| South Asian | 0.0044 | 0.0044 | notable |
| Other | 0.0082 | 0.0082 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Protein phosphatase that may contribute to contact inhibition of cell growth and motility by mediating the dephosphorylation of focal adhesion-associated substrates and thus negatively regulating integrin-promoted signaling processes. Induces apoptotic cell death by at least two distinct mechanisms: inhibition of cell survival signaling mediated by PI 3-kinase, Akt, and ILK and activation of a caspase-dependent proapoptotic pathway. Inhibits the basal activity of LCK and its activation in response to TCR stimulation and TCR-induced activation of MAP kinase and surface expression of CD69. Inhibits TCR-induced tyrosine phosphorylation of LAT and ZAP70. Inhibits both basal activity of DOK1 and its CD2-induced tyrosine phosphorylation. Induces dephosphorylation of BCAR1, focal adhesion kinase and SRC. Reduces migratory activity of activity of Jurkat cells. Reduces tyrosine phosphorylation of CEACAM20 and thereby contributes to suppress the intestinal immune response CEACAM20 (By similarity). {ECO:0000250|UniProtKB:E9Q0N2, ECO:0000269|PubMed:11278335, ECO:0000269|PubMed:12101188, ECO:0000269|PubMed:12837766, ECO:0000269|PubMed:15850787}.;
Intolerance Scores
- LoFtool
- 0.573
- RVIS EVS
- 1.11
- RVIS percentile EVS
- 92.07
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.581
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |